Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Toxicity to reproduction

Currently viewing:

Administrative data

Endpoint:
one-generation reproductive toxicity
Remarks:
based on test type (migrated information)
Type of information:
migrated information: read-across based on grouping of substances (category approach)
Adequacy of study:
key study
Study period:
281 days overall
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: No GLP

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1979

Materials and methods

Test guideline
Qualifier:
no guideline available
Principles of method if other than guideline:
This study was conducted to assess the long-term effects of CP 41863 when administered continuously via the diet to Long-Evans rats at concentrations of 300, 1000 and 3000 ppm through onecomplete generation. Test substance administration to the F0 generation females (201group) was initiated at the onset of gestation and continued throughout the ensuing gestation and lactation periods. Dietary administration of CP 41863 continued to the F1 generation animals (10 males and 20 females/group) through a growth period and mating, gestation and l actation period for two successive litters.
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
[ethane-1,2-diylbis[nitrilobis(methylene)]]tetrakisphosphonic acid
EC Number:
215-851-5
EC Name:
[ethane-1,2-diylbis[nitrilobis(methylene)]]tetrakisphosphonic acid
Cas Number:
1429-50-1
Molecular formula:
C6H20N2O12P4
IUPAC Name:
{ethane-1,2-diylbis[nitrilobis(methylene)]}tetrakis(phosphonic acid)
Constituent 2
Reference substance name:
Ethylenediaminetetra (methylene phosphonic acid)
IUPAC Name:
Ethylenediaminetetra (methylene phosphonic acid)
Details on test material:
Ethylenediaminetetra (methylene phosphonic acid) % active ingredient = 93.3%

Test animals

Species:
rat
Strain:
Long-Evans
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: B1 ue Spruce Farms A1 tamont, N.Y.
- Age at study initiation: (P) 15-16 weeks
- Housing:Individually in elevated stainless steel cages (except during mating).
- Diet (e.g. ad libitum):Standard laboratory diet (Purina Laboratory Chow@ 5001 )
-ad l ibitum.
- Water (e.g. ad libitum):ad libitum
- Acclimation period: 19 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C):Temperature monitored twice daily
- Humidity (%): Not stated
- Air changes (per hr):Not stated
- Photoperiod (hrs dark / hrs light):12 hour l i ght/dark cycle.

Administration / exposure

Route of administration:
oral: feed
Details on exposure:
PREPARATION OF DOSING SOLUTIONS:No information
- Lot/batch no. (if required):176-18-8-B
- Purity:93.3%
Details on mating procedure:
F0 Females: Females were p1aced w ith male rats nightly in a r a t i o of 2:l. Vaginal smears were taken early in
the morning and females were considered t o have mated if sperm and/or vaginal plug was observed. The day on which evidence of
mating was observed was defined as Day 0 of gestation.

F1 Females: One male and two females of equivalent dose l e l v e l s were caged together nightly for 15 nights or until a sign of mating (sperm and/or vaginal plug) was observed. Care was taken t o avoid brother-sister mating. The day on which evidence of mating was observed was defined as Day 0 of gestation.
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
Test substance was administered continuously , beginning Day 0 of
gestation for the F0 females and continued for the F1 males and females through the F2a and F2b
litters.

Age of F0 and initiation of test substance administration: 15-16 weeks.
Frequency of treatment:
Daily
Details on study schedule:
Test substance administration of the F0 females was initiated the day signs of mating were observed (Day 0 of gestation) and continued throughout
the ensuing gestation and l actation periods. F1 offspring were separated from siblings seven days after the weaning (Day 21 of lactation) of the last litter and were randomly selected to continue as future parents ( F1 ).

F1 animals were raised to maturity and mated to produce the F2, litters . Fea pups were sacrificed, necropsied and discarded at weaning. All
F1 females were remated after a rest period of at least 14 days to produce theF2b litters . F2b pups were sacrificed and necropsied a t weaning.
Doses / concentrations
Remarks:
Doses / Concentrations:
Administered in the diet
Basis:
other: 0,300,1000,3000 ppm
No. of animals per sex per dose:
Fo - (females) - 20/group
F1 - (males and females) - 10 M + 20 F /group
Control animals:
yes

Examinations

Parental animals: Observations and examinations:
CAGE SIDE OBSERVATIONS: Yes
Physical observations -twice daily.For mortality and gross signs of toxicologic or pharmacologic effects. (Fo, F1 parents)
Detailed physical observations - for signs of local or systemic toxicity, pharrnacologic effects and palpation for tissue masses (Fo, F1 p a r e n t s ) :

DETAILED CLINICAL OBSERVATIONS: Yes / No / No data
- Time schedule:

BODY WEIGHT: Yes
- Mean maternal body weight during gestation and lactation; mean pup body weight recorded at days 0,4,14,21 of lactation; mean body weight recorded during F1 growth and rest periods.

FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes / No / No data
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes / No / No data


Results and discussion

Results: P0 (first parental generation)

Effect levels (P0)

Dose descriptor:
NOAEL
Effect level:
> 3 000 ppm
Based on:
labile/free
Remarks:
acid
Sex:
male/female

Results: F1 generation

Effect levels (F1)

Dose descriptor:
NOEL
Generation:
F1
Effect level:
> 3 000 ppm
Based on:
labile/free
Remarks:
acid
Sex:
male/female

Overall reproductive toxicity

Reproductive effects observed:
not specified

Any other information on results incl. tables

F0 generation - No treatment related effects were evident in respect to growth, food consumption, reproductive-fertility, or litter examination parameters. At terminal sacrifice, the mid dose males and high dose animals had lower body weights. In the mid and high dose levels, males had higher adrenal weights both absolute and relative to body and brain weights. High dose females had higher thyroid/body and spleen/body weight ratios. however organ to brain weight ratios revealed no treatment effect in the F1 females.

Gross postmortem observations and evaluation of selected tissues from five adult F1 generation males and females of the control (Groups I and II) and high dose (Group V) groups indicated no treatment related effects.

No treatment related effects on any of the reproductive parameters. (Mating, fertility; pregnancy, parturition & survival)

Applicant's summary and conclusion

Executive summary:

In a one generation reproductive toxicity study, the test substance was administered continuously via the diet to Long-Evans F0 generation females (20/group) at the onset of gestation and continued throughout the ensuing gestation and lactation periods. Dietary administration was continued to the F1 generation animals (10 males and 20 females /group) through a growth period and a mating, gestation and lactation period for two successive litters.

In the F0 generation, no treatment effects were evident in the low or mid dose groups. In the F1 generation, no treatment effects were observed in growth, food consumption, fertility-reproduction or litter examination parameters. At terminal sacrifice, mid dose males an high dose animals had lower body weights. In the mid and high dose levels, males had higher adrenal weights, both absolute and relative to body and brain ratios.

However in the absence of histopathological/clinical pathology examination results, it is not clear whether or not the weight change a real effect.In the absence of adverse clinical /reproductive effects for this substance it is unlikely to be of toxicological significance.

Therefore the NOAEL for reproductive effects for F0 and F1 is > 3000 ppm.